Intestinal microbiota, fecal microbiota transplantation, and inflammatory bowel disease

Alexa R. Weingarden, Byron P. Vaughn

Research output: Contribution to journalReview articlepeer-review

239 Scopus citations


Inflammatory bowel disease (IBD) is a complex set of diseases that lead to chronic inflammation in the gastrointestinal tract. Although the etiology of IBD is not fully understood, it is well-known that the intestinal microbiota is associated with the development and maintenance of IBD. Manipulation of the gut microbiota, therefore, may represent a target for IBD therapy. Fecal microbiota transplantation (FMT), where fecal microbiota from a healthy donor is transplanted into a patient's GI tract, is already a successful therapy for Clostridium difficile infection. FMT is currently being explored as a potential therapy for IBD as well. In this review, the associations between the gut microbiota and IBD and the emerging data on FMT for IBD will be discussed.

Original languageEnglish (US)
Pages (from-to)238-252
Number of pages15
JournalGut microbes
Issue number3
StatePublished - May 4 2017

Bibliographical note

Publisher Copyright:
© 2017 Taylor & Francis.


  • Crohn's disease
  • Inflammatory Bowel Disease
  • fecal microbiota transplant
  • ulcerative colitis


Dive into the research topics of 'Intestinal microbiota, fecal microbiota transplantation, and inflammatory bowel disease'. Together they form a unique fingerprint.

Cite this